November 18, 2026
Health news, explained with evidence
LIVE
JAK Inhibitor Shows Potential in Managing Immune Dysregulation in Down Syndrome Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women Investigational Quadruple Receptor Agonist Shows Weight Loss Potential in Phase II Trial CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities JAK Inhibitor Shows Potential in Managing Immune Dysregulation in Down Syndrome Understanding and Addressing Love Handles Through Lifestyle Changes Ciele Releases New Woolmark-Certified Merino Winter Running Apparel Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women Investigational Quadruple Receptor Agonist Shows Weight Loss Potential in Phase II Trial CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities

Researchers Identify Molecular Mechanism Behind Intervertebral Disc Degeneration

🏥 Public Health 2 min read 👁 6

A recent study published in Nature Health Sciences uncovers how a specific regulatory protein drives cell damage in spinal disc degeneration and points to potential new treatments.

🏥Public Health

Key points

  • USP14 enzyme levels are elevated in degenerative spinal disc tissues.
  • Targeting USP14 helps restore protective autophagy and reduces cell damage.
  • Preclinical testing in rat models showed that local delivery of IU-1 reduced disc degeneration.

A collaborative team of researchers has uncovered a specific molecular pathway that accelerates intervertebral disc degeneration, a widespread condition linked to nutrient deprivation in spinal tissues. Investigating human and rat degenerative tissues, the study revealed that an enzyme called deubiquitinase USP14 is amplified during cellular stress, leading to the breakdown of spinal disc cells and extracellular matrix.

According to the findings, USP14 stabilizes leucyl-tRNA synthetase, which in turn hyperactivates the mTORC1 signaling pathway and suppresses protective cellular autophagy. When the research team used genetic techniques or pharmacological inhibitors such as IU-1 to target USP14, they observed a restoration of autophagic activity and reduced cellular damage in laboratory models. Furthermore, delivering IU-1 directly into the intervertebral discs of rat models successfully mitigated the progression of degeneration.

While these preclinical findings offer promising insights into potential therapies for back pain and disc disease, experts note that the work is still in early laboratory and animal stages. Clinical applications in humans will require extensive further investigation and human trials. Readers experiencing chronic back pain or spinal conditions should consult a qualified physician before considering any experimental treatments.

What to know: Scientists discovered that blocking the USP14 enzyme can protect spinal disc cells from nutrient stress by restoring autophagy, offering a possible target for future treatments.

Source Nature Health Sciences — nature.com/articles/s41419-026-09377-7 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.